Figure 13 — Development and validation of a novel epigenetic-related prognostic signature and candidate drugs for patients with lung adenocarcinoma

Navigate

Research Paper|Volume 13, Issue 14|pp. 18701–18717

Development and validation of a novel epigenetic-related prognostic signature and candidate drugs for patients with lung adenocarcinoma

Back to articleFigure 13(13 of 13)

100%

Figure 13.Results of CMap analysis.

Figure 13 — Development and validation of a novel epigenetic-related prognostic signature and candidate drugs for patients with lung adenocarcinoma | Aging